Evaluating Alterations and Indicators of Blood Cell Among Individuals Referred to the City Hospital in 2023

Abstract

Background: Changes in blood cell parameters can provide valuable insights into an individual's health status. This study aimed to evaluate alterations and indicators of blood cells among individuals referred to a city hospital in 2023.

Methods: A retrospective analysis was conducted on the medical records of patients who visited the city hospital during the year 2023. Complete blood count (CBC) data, including red blood cells (RBCs), white blood cells (WBCs), and platelet counts, were collected and analyzed. Deviations from the normal reference ranges were identified, and the prevalence of various blood cell alterations was determined.

The mean RBC, hemoglobin, and hematocrit levels were 1.18 million/cumm, 1.29 g/dL, and 1.51%, respectively. Most participants had normal RBC (84.9%), hemoglobin (71.6%), and hematocrit (56.3%) levels. The mean MCV, MCH, and MCHC were 1.30 fL/red cell, 1.36 pg/red cell, and 1.14 g/dL RBC, with abnormalities observed in 29.0%, 34.1%, and 11.8% of participants. The mean total WBC count was 9,486.50/mm3, with normal differential counts in the majority. The mean platelet count was 286,475.62/mm3, with 85.5% having normal levels.

Conclusion: This study provides insights into the alterations and indicators of blood cells among individuals referred to the city hospital in 2023. The findings highlight the importance of regular blood cell monitoring and the need for comprehensive clinical assessment to identify and manage potential health issues. These results can contribute to the development of targeted interventions and improved patient care.